FDA Approved: RASAGILINE MESYLATE — Original Application (Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Avet Pharmaceuticals' original application for rasagiline mesylate as a generic treatment option for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rasagiline mesylate (RASAGILINE MESYLATE)

Snippet

ORIG AP for RASAGILINE MESYLATE (RASAGILINE MESYLATE)